1. Kennedy, K., Sarohia, G., Podbielski, D., Pickard, S., Tarride, J.E., Xie, F.: Systematic methodological review of health state values in glaucoma cost-utility analyses. Eur. J. Health Econ. (2024). https://doi.org/10.1007/s10198-023-01663-x
2. Annemans, L., Genesté, B., Jolain, B.: Early modelling for assessing health and economic outcomes of drug therapy. Value Health. 3, 427–434 (2000). https://doi.org/10.1046/j.1524-4733.2000.36007.x
3. IJzerman, M.J., Koffijberg, H., Fenwick, E., Krahn, M.: Emerging use of early health technology assessment in medical product development: A scoping review of the literature. Pharmacoeconomics. 35, 727–740 (2017). https://doi.org/10.1007/s40273-017-0509-1
4. Drummond, M.F., Sculpher, M.J., Claxton, K., Stoddart, G.L., Torrance, G.W.: Methods for the Economic Evaluation of Health care Programmes, 4th edn. Oxford University Press, Oxford (2015)
5. Neumann, P.J., Sanders, G.D., Russell, L.B., Siegel, J.E., Ganiats, T.G. (eds.): Cost-effectiveness in Health and Medicine, 2nd edn. Oxford University Press, New York (2016)